Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
29.19B | 27.32B | 25.79B | 23.35B | 20.27B | 20.46B | Gross Profit |
4.37B | 4.46B | 5.06B | 4.88B | 3.50B | 3.50B | EBIT |
1.78B | 2.01B | 2.64B | 2.57B | 1.47B | 1.45B | EBITDA |
1.84B | 2.08B | 2.69B | 2.55B | 1.55B | 1.49B | Net Income Common Stockholders |
1.09B | 1.26B | 1.74B | 1.62B | 934.82M | 869.78M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
6.45B | 6.87B | 4.79B | 5.49B | 5.54B | 3.61B | Total Assets |
29.95B | 26.85B | 27.43B | 24.44B | 20.56B | 18.50B | Total Debt |
17.64B | 14.63B | 15.64B | 13.40B | 11.18B | 10.04B | Net Debt |
11.19B | 8.49B | 10.84B | 7.91B | 5.64B | 6.43B | Total Liabilities |
18.76B | 15.77B | 17.12B | 15.21B | 12.46B | 11.09B | Stockholders Equity |
11.19B | 11.08B | 10.30B | 9.23B | 8.10B | 7.41B |
Cash Flow | Free Cash Flow | ||||
0.00 | 3.57B | -2.34B | -1.56B | 1.00B | 766.76M | Operating Cash Flow |
0.00 | 4.55B | -706.53M | -1.28B | 2.75B | 1.30B | Investing Cash Flow |
0.00 | -1.25B | -1.55B | -434.60M | -1.75B | -532.27M | Financing Cash Flow |
0.00 | -1.50B | 1.58B | 1.67B | 905.75M | -603.24M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
73 Outperform | ¥3.99T | 19.88 | 6.51% | 1.92% | 0.83% | -6.10% | |
72 Outperform | $718.89B | 10.10 | 9.23% | 3.14% | 6.15% | 12.10% | |
69 Neutral | $529.33B | 8.03 | 12.46% | 3.36% | 23.35% | 46.19% | |
68 Neutral | $3.00T | 15.61 | 8.35% | 1.56% | 16.32% | 43.72% | |
67 Neutral | ¥8.89B | 7.80 | 5.87% | 20.37% | 6.07% | ||
59 Neutral | $2.73B | 11.72 | 0.09% | 8795.52% | 5.45% | -17.33% | |
50 Neutral | ¥286.59B | ― | -6.36% | 1.94% | 10.79% | -118.53% |